Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Interactions Between Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Major Respiratory Viruses in Human Nasal Epithelium.
Pizzorno A, Padey B, Dulière V, Mouton W, Oliva J, Laurent E, Milesi C, Lina B, Traversier A, Julien T, Trouillet-Assant S, Rosa-Calatrava M, Terrier O. Pizzorno A, et al. Among authors: duliere v. J Infect Dis. 2022 Dec 13;226(12):2095-2104. doi: 10.1093/infdis/jiac357. J Infect Dis. 2022. PMID: 36031537 Free PMC article.
Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia.
Pizzorno A, Padey B, Julien T, Trouillet-Assant S, Traversier A, Errazuriz-Cerda E, Fouret J, Dubois J, Gaymard A, Lescure FX, Dulière V, Brun P, Constant S, Poissy J, Lina B, Yazdanpanah Y, Terrier O, Rosa-Calatrava M. Pizzorno A, et al. Among authors: duliere v. Cell Rep Med. 2020 Jul 21;1(4):100059. doi: 10.1016/j.xcrm.2020.100059. Cell Rep Med. 2020. PMID: 32835306 Free PMC article.
Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs.
Lopez J, Mommert M, Mouton W, Pizzorno A, Brengel-Pesce K, Mezidi M, Villard M, Lina B, Richard JC, Fassier JB, Cheynet V, Padey B, Duliere V, Julien T, Paul S, Bastard P, Belot A, Bal A, Casanova JL, Rosa-Calatrava M, Morfin F, Walzer T, Trouillet-Assant S. Lopez J, et al. Among authors: duliere v. J Exp Med. 2021 Oct 4;218(10):e20211211. doi: 10.1084/jem.20211211. Epub 2021 Aug 6. J Exp Med. 2021. PMID: 34357402 Free PMC article.
Avian Cell Line DuckCelt®-T17 Is an Efficient Production System for Live-Attenuated Human Metapneumovirus Vaccine Candidate Metavac®.
Chupin C, Pizzorno A, Traversier A, Brun P, Ogonczyk-Makowska D, Padey B, Milesi C, Dulière V, Laurent E, Julien T, Galloux M, Lina B, Eléouët JF, Moreau K, Hamelin ME, Terrier O, Boivin G, Dubois J, Rosa-Calatrava M. Chupin C, et al. Among authors: duliere v. Vaccines (Basel). 2021 Oct 16;9(10):1190. doi: 10.3390/vaccines9101190. Vaccines (Basel). 2021. PMID: 34696298 Free PMC article.
Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs.
Lopez J, Mommert M, Mouton W, Pizzorno A, Brengel-Pesce K, Mezidi M, Villard M, Lina B, Richard JC, Fassier JB, Cheynet V, Padey B, Duliere V, Julien T, Paul S, Bastard P, Belot A, Bal A, Casanova JL, Rosa-Calatrava M, Morfin F, Walzer T, Trouillet-Assant S. Lopez J, et al. Among authors: duliere v. J Exp Med. 2021 Oct 4;218(10):jem.2021121108132021c. doi: 10.1084/jem.2021121108132021c. Epub 2021 Aug 20. J Exp Med. 2021. PMID: 34415984 Free PMC article. No abstract available.
Transcriptional Profiling of Immune and Inflammatory Responses in the Context of SARS-CoV-2 Fungal Superinfection in a Human Airway Epithelial Model.
Nicolas de Lamballerie C, Pizzorno A, Fouret J, Szpiro L, Padey B, Dubois J, Julien T, Traversier A, Dulière V, Brun P, Lina B, Rosa-Calatrava M, Terrier O. Nicolas de Lamballerie C, et al. Among authors: duliere v. Microorganisms. 2020 Dec 11;8(12):1974. doi: 10.3390/microorganisms8121974. Microorganisms. 2020. PMID: 33322535 Free PMC article.